Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy
多发性骨髓瘤患者的临床和生物学特征会影响对elotuzumab联合疗法的反应。
期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-018-2807-1
Danhof, Sophia; Strifler, Susanne; Hose, Dorothea; Kortüm, Martin; Bittrich, Max; Hefner, Jochen; Einsele, Hermann; Knop, Stefan; Schreder, Martin
